Preventive Effect of Dexamethasone Therapy on the Transient Hypoparathyroidism through Total Thyroidectomy.

Publisher: Mashhad University of Medical Sciences Country of Publication: Iran NLM ID: 101577699 Publication Model: Print Cited Medium: Print ISSN: 2251-7251 (Print) Linking ISSN: 22517251 NLM ISO Abbreviation: Iran J Otorhinolaryngol Subsets: PubMed not MEDLINE

Original Publication: Mashhad : Mashhad University of Medical Sciences

Introduction: This study aimed to investigate whether pre-operative dexamethasone could ameliorate transient hypoparathyroidism outcome through total thyroidectomy.
Materials and Methods: This randomized clinical trial study was conducted on 128 patients underwent total thyroidectomy from March 2014 to April 2015. Patients were randomly assigned to two groups of experimental receiving 8 mg IV of intravenous dexamethasone (n=45) 45 min before skin incision treatment and control (n=83). After the surgery, all patients were evaluated for clinical and laboratory hypocalcaemia.
Results: Post-operative transient biochemical hypoparathyroidism and hypocalcaemia did not occur more often in the control group, compared to the dexamethasone group while controlling for the baseline variables. However, there was a significant difference in phosphorus level between the dexamethasone and control groups (P=0.028). A total of 50 (39.1%) patients developed hypocalcaemia after surgery. Moreover, post-operative symptomatic hypocalcemia occurred more frequently in the control group (68%) compared to the dexamethasone group (32%); however, this difference was not statistically significant (P=0.54).
Conclusion: The pre-operative administration of dexamethasone reduced post-operative hypocalcemia rate. It is essential to conduct future studies with validated means for better results.

Endocr Rev. 2000 Feb;21(1):55-89. (PMID: 10696570)
World J Surg. 2000 Aug;24(8):971-5. (PMID: 10865043)
Acta Otolaryngol. 2002 Sep;122(6):679-83. (PMID: 12403134)
J Am Coll Surg. 2002 Nov;195(5):694-712. (PMID: 12437261)
Chirurg. 2003 May;74(5):437-43. (PMID: 12748792)
World J Surg. 2004 Mar;28(3):271-6. (PMID: 14961204)
Br J Surg. 2004 May;91(5):569-74. (PMID: 15122607)
Am J Physiol Lung Cell Mol Physiol. 2004 Oct;287(4):L774-83. (PMID: 15180920)
Ann Surg. 2004 Jul;240(1):18-25. (PMID: 15213613)
World J Surg. 2006 Mar;30(3):299-303. (PMID: 16479340)
Otolaryngol Head Neck Surg. 2007 Oct;137(4):654-8. (PMID: 17903586)
Arch Surg. 2008 Feb;143(2):132-7; discussion 138. (PMID: 18283137)
Br J Surg. 2008 Dec;95(12):1480-7. (PMID: 18991283)
Head Neck. 2011 Jun;33(6):840-6. (PMID: 20737495)
Ann Surg. 2011 Aug;254(2):183-91. (PMID: 21694581)
Acta Otorhinolaryngol Ital. 2011 Jun;31(3):144-8. (PMID: 22064813)
JAMA Otolaryngol Head Neck Surg. 2013 May;139(5):471-8. (PMID: 23681030)
Am Surg. 2013 Dec;79(12):1258-62. (PMID: 24351352)
Br J Surg. 2014 Mar;101(4):307-20. (PMID: 24402815)
Eur Arch Otorhinolaryngol. 2014 Nov;271(11):3073-6. (PMID: 24964771)
PLoS One. 2014 Oct 16;9(10):e109582. (PMID: 25330115)
Ann Surg. 2015 Dec;262(6):934-40. (PMID: 25563879)
Langenbecks Arch Surg. 2015 Dec;400(8):929-36. (PMID: 26545607)
Korean J Anesthesiol. 2017 Feb;70(1):64-71. (PMID: 28184269)
Gland Surg. 2017 Dec;6(Suppl 1):S38-S48. (PMID: 29322021)
Gland Surg. 2017 Dec;6(Suppl 1):S59-S68. (PMID: 29322023)
Arch Otolaryngol Head Neck Surg. 1988 Feb;114(2):168-74. (PMID: 3337775)
Acta Endocrinol (Copenh). 1985 Jun;109(2):220-6. (PMID: 4013612)
Br J Surg. 1997 Jan;84(1):95-7. (PMID: 9043468)
World J Surg. 1998 Jul;22(7):718-24. (PMID: 9606288)
Can J Anaesth. 1998 Sep;45(9):871-9. (PMID: 9818111)

Keywords: Drug Utilization; Hypoparathyroidism; dexamethasone; surgery

Date Created: 20190417 Latest Revision: 20220408

20240829

PMC6449529

30989072